5661 Blood Drug Analysis (2024) Price: $550.00
Participants will receive 20mL of human whole blood or animal blood for each of four testing items which contain unknown concentrations of various drugs and/or metabolites, including the possibility of a negative sample. Qualitative and quantitative results will be gathered. Analyte concentrations are presented in case-like ranges for Medicolegal Death Investigations, Impaired Driving Investigations, Drug-Facilitated Crime Investigations, or Workplace Testing.
The purpose of this test is the examination of drugs listed in section 1308 of Title 21 Code of Federal Regulations under the United States Controlled Substances Act that fall into the following classes: benzodiazepines, nonbenzodiazepine hypnotics (z-drugs), barbiturates, opioids, illicit hallucinogens, illicit stimulants, illicit depressants, and cannabinoids. A key feature of this test offering is the ability to perform toxicological analysis on four separate blood testing items. Each testing item is split into duplicate 10mL vials, as is often the case with forensic samples.
This test is included on CTS' Scope of Accreditation to ISO/IEC 17043:2010.
Samples ship in April.
Enrollment deadline: 1 November 2023